Hangzhou Alltest Biotech Co., Ltd. (SHA:688606)
China flag China · Delayed Price · Currency is CNY
70.60
+1.06 (1.52%)
At close: Jan 23, 2026

Hangzhou Alltest Biotech Company Description

Hangzhou Alltest Biotech Co., Ltd. engages in the research, development, production, and sale of in vitro diagnostic reagents in China and internationally.

The company offers rapid diagnostic reagents, including drug and drug abuse, infectious disease, women's health, tumor marker, and cardiac marker testing products.

Its products include COVID-19 antigen and antibody tests; veterinary tests; fluorescence immunoassay tests and analyzers; urine analysis solutions, biochemistry reagents, VTM, blood glucose monitoring systems, and HB hemoglobin test meters.

In addition, the company offers SARS-COV-2 RT-qPCR assays, virus specimen stabilizers, and viral DNA/RNA extraction kits; and other test products.

Its products are used in clinical testing, on-site testing, personal health management, and other fields.

Hangzhou Alltest Biotech Co., Ltd. was founded in 2009 and is based in Hangzhou, China.

Hangzhou Alltest Biotech Co., Ltd.
CountryChina
Founded2009
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees969
CEOFei Gao

Contact Details

Address:
Building 3, 4, 5
Hangzhou, 310018
China
Phone86 57 1562 07860
Websitealltests.com.cn

Stock Details

Ticker Symbol688606
ExchangeShanghai Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE1000053G6
SIC Code2835

Key Executives

NamePosition
Fei GaoChairman and GM
Yanping FuAccounting Supervisor, Chief Financial Officer and Secretary of the Board of Directors
Weike LuDeputy GM and Director